MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4+ T cells in healthy volunteers

Human Immunology

Volumn 65, Issue 5, 2004, Pages 507-513

  Ye, Ming ^a   Kasey, Suha ^a   Khurana, Sumit ^a   Nguyen, Nga T ^a   Schubert, Scott ^a   Nugent, C Thomas ^a   Kuus Reichel, Kristine ^a   Hampl, Johannes ^a  

^a BECKMAN COULTER INC   (United States)

Author keywords

Epstein Barr virus; HLA DR; immune monitoring; influenza hemagglutinin; MHC class II tetramer

Indexed keywords

EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETRAMER; VIRUS HEMAGGLUTININ;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DONOR; HUMAN; INFLUENZA VIRUS; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RELIABILITY; T LYMPHOCYTE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLOW CYTOMETRY; FLUORESCEINS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HEMAGGLUTININS, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PEPTIDE FRAGMENTS; SUCCINIMIDES;

EID: 2542458242     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.02.019     Document Type: Article

References (15)

1. +) T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood. 98:2001;1358
2. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.-M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., Beaudry K., Lifton M.A., Nickerson C.E., Trigona W.L., Punt K., Freed D.C., Guan L., Dubey S., Casimiro D., Simon A., Davies M.-E., Chastain M., Strom T.B., Gelman R.S., Montefiori D.C., Lewis M.G., Emini E.A., Shiver J.W., Letvin N.L. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290:2000;486
3. Crawford F., Kozono H., White J., Marrack P., Kappler J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:1998;675
4. + T cells proliferating in response to influenza A antigen. J Clin Invest. 104:1999;R63
5. Meyer A.L., Trollmo C., Crawford F., Marrack P., Steere A.C., Huber B.T., Kappler J., Hafler D.A. Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc Natl Acad Sci U S A. 97:2000;11433
6. + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J Immunol. 166:2001;741
7. Savage P.A., Davis M.M. A kinetic window constricts the T cell receptor repertoire in the thymus. Immunity. 14:2001;243
8. Khanna R., Burrows S.R., Steigerwald-Mullen P.M., Thomson S.A., Kurilla M.G., Moss D.J. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1 implications for viral persistence and tumor surveillance. Virology. 214:1995;633
9. Lamb J.R., Eckels D.D., Lake P., Woody J.N., Green N. Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature. 300:1982;66
10. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A., Strominger J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:1992;764
11. Demotz S., Lanzavecchia A., Eisel U., Niemann H., Widmann C., Corradin G. Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol. 142:1989;394
12. Hall F.C., Visconti K.C., Ahmad R.C., Parry S.L., Miltenburg A.M., McConnell H.M., Mellins E.D., Sonderstrup G. Cytokines elicited by T cell epitopes from a synovial autoantigen altered peptide ligands can reduce interferon-gamma and interleukin-10 production. Arthritis Rheum. 48:2003;2375
13. Lyons A.B., Doherty K.V. Flow cytometric analysis of cell divison by dye dilution. Robinson J.P., Darzynkiewicz Z., Dean P.N., Hibbs A.R., Orfao A., Rabinovitch P.S., Wheeless L.L. Current Protocols in Cytometry 1998 (Suppl 6, Unit 9.11). 1998;John Wiley & Sons, Inc, New York
14. Fink P.J., Shimonkevitz R.P., Bevan M.J. Veto cells. Annu Rev Immunol. 6:1988;115
15. Stone J.D., Cochran J.R., Stern L.J. T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model. Biophys J. 81:2001;2547